Navigation Links
AMDL Reaffirms 2008 Guidance and Provides Additional Information
Date:9/15/2008

TUSTIN, Calif., Sept. 15 /PRNewswire-FirstCall/ -- AMDL, Inc. (Amex: ADL), a vertically integrated pharmaceutical company with major operations in China and the US, announced today it is reaffirming guidance for Q3 and FY2008. Additionally, the Company is providing information for the benefit of stockholders in response to the heightened activity in its common stock on the American Stock Exchange (AMEX) in recent days.

While it is the Company's normal policy to not comment on unusual trading activity or changes in the Company's quoted stock price or to provide updated guidance between quarterly conference calls, the Company has recently received numerous inquiries requesting updated guidance in light of recent developments in general market conditions and the China and US pharmaceutical sector.

In response to specific inquiries from stockholders, AMDL is reiterating previously issued guidance and providing additional information as follows:

-- The Company has stated anticipated net sales of $13 million for the third quarter 2008. The Company believes it will achieve this primarily through continued distribution and sales for its top-selling products in China, which have shown consistent returns for the last 8 quarters.

-- The Company reaffirms it is on track to achieve its paramount goal for 2008, which is to once again achieve record annual earnings in 2008 with a 100% increase in sales over 2007. For FY2008 AMDL has targeted net sales ranging between $30 to $38.7 million with gross margins of 46% to 52% -- a 100% increase over the same period in 2007 where the Company achieved gross revenues of $15 million with a gross margin of 54%..

-- Potential revenues for AMDL's ELISA DR-70(R) (FDP) in vitro diagnostic (IVD) test which was approved the US FDA on July 3, 2008 for the monitoring of colorectal cancer are not included in AMDL's 2008 guidance forecast. The Company has presented DR-70 technology to both US and International
'/>"/>

SOURCE AMDL, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Grocery Manufacturers Association: FDA Once Again Reaffirms Safety of Bisphenol A (BPA) for All Consumers
2. Lotus Pharmaceuticals, Inc. Reaffirms its Confidence in Meeting its Make Good Target for Fiscal Year 2008
3. Biopure Reaffirms Strategy Following Recent NIH/FDA Workshop
4. Gentiva(R) Health Services Announces First Quarter 2008 Results and Reaffirms Financial Outlook
5. Grocery Manufacturers Association: Canadian Risk Assessment Reaffirms Safety of Bisphenol A (BPA) for Adults and Children
6. Abbott Reports Double-Digit Sales and Earnings Growth in First Quarter and Reaffirms Full-Year Growth Outlook
7. Omnicell Announces Common Stock Repurchase Program; Reaffirms Earnings Forecast
8. Accipiter Capital Management Reaffirms Its Opposition to the Acquisition of VistaCare, Inc. by Odyssey Healthcare, Inc.
9. Hanger Orthopedic Group, Inc. Announces Senior Leadership Succession Plan and Reaffirms Guidance
10. Cardinal Health Reaffirms Fiscal 2008 EPS Guidance, Updates Segment Profit Outlook
11. New Study of Aspartame Research Reaffirms Safety, Even Among Heaviest Users
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2014)... the depletion of self-control, according to research published in ... for Psychological Science. , Self-control can be difficult ... on a boring textbook are hard things to do. ... Exerting self-control for a long period seems to "deplete" ... , "It is as if self-control is a limited ...
(Date:4/22/2014)... industry leaders visited the New Jersey Institute of ... S. Bloom for the launch of the New ... provides a new model for business innovation through ... assets and investment. U.S. Senator Cory Booker, Panasonic ... Taylor, New Jersey Lieutenant Governor Kim Guadagno, New ...
(Date:4/22/2014)... at UT Southwestern Medical Center are making breakthroughs that ... A team of physician-scientists at UT Southwestern has ... with natural anti-depressant properties) works inside the brain. Simultaneously, ... depression in the form of a neuroprotective drug known ... in April,s issue of Molecular Psychiatry, is ...
(Date:4/22/2014)... Washington, DC (April 22, 2014) The International ... May 22-26 in Seattle, Washington. The theme of ... life" means in a networked and digital society. ... and attended by over 2,200 Communication scholars representing ... largest scholarly international communication conference in the world. ...
(Date:4/22/2014)... latest scientific advances and emerging therapies in heart failure ... annual meeting of the Heart Failure Association (HFA) of ... hear breaking news on acute heart failure during the ... part of the main congress. , The event will ... Megaron Athens International Conference Centre (MAICC). The full scientific ...
Breaking Medicine News(10 mins):Health News:ADHD drug may help preserve our self-control resources 2Health News:Government and industry leaders herald launch of NJIT's New Jersey Innovation Institute 2Health News:Depressed? Researchers identify new anti-depressant mechanisms, therapeutic approaches 2Health News:Depressed? Researchers identify new anti-depressant mechanisms, therapeutic approaches 3Health News:International Communication Association to hold Annual Conference in Seattle, Washington 2Health News:The world's largest heart failure congress 2Health News:The world's largest heart failure congress 3
... gender and weight, play role in infant,s chances, study ... When it comes to the survival of premature infants, ... gestational age, but a new study suggests that gestational ... and parents should consider when deciding what treatment, if ...
... -- Lotus,Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) (,Lotus, or ... China,("PRC"), today announced financial results for the fourth quarter ... Quarter 2007 Highlights -- Total revenues increased to ... quarter of 2006 -- Gross profit ...
... April 17 ProGenTech, a life,sciences company based ... to,announce that it has made several executive management ... Dr. Paul Richardson has joined ProGenTech as ... Dr. Richardson will lead the global R&D programs,and ...
... CRM Holdings,Ltd. ("the Company") (Nasdaq: CRMH ) ... wholly-owned subsidiary of the Company, has,received notice from ... following an initial investigation, the WCB has determined ... CRM,s third party,administrator,s license to provide third party ...
... 16 The California Nurses,Association,s (CNA) insistence on presenting ... the Service Employees International,Union (SEIU) reached new levels this ... admit photos it claimed as evidence of,"violence by protesters" ... images of SEIU staff and members injured by conference ...
... Consumer,Watchdog today joined L.A. City Attorney Rocky Delgadillo ... Blue Cross engaged in unfair,business practices by illegally ... sick., The practice -- known as "rescission" ... have been left uninsured, uninsurable, and facing up ...
Cached Medicine News:Health News:Gestational Age Not Sole Predictor of Preemie Survival 2Health News:Gestational Age Not Sole Predictor of Preemie Survival 3Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 2Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 3Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 4Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 5Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 6Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 7Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 8Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 9Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 10Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 11Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 12Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 13Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 14Health News:ProGenTech Limited Appoints Executive Management Team 2Health News:Compensation Risk Managers, LLC Receives Notice of Administrative Action by New York Workers' Compensation Board 2Health News:Compensation Risk Managers, LLC Receives Notice of Administrative Action by New York Workers' Compensation Board 3Health News:Consumer Watchdog Applauds L.A. City Attorney's Efforts to Reinstate Cancelled Blue Cross Patients; Urges State HMO Regulator to Immediately Reinstate Coverage 2
(Date:1/15/2014)... , Jan. 15, 2014  In an unprecedented effort to curb the ... ambulances and other transport vehicles, an advanced and portable UV germicidal ... for the first time. In order to prevent ... deadly pathogens, West Palm Beach Fire Rescue ...
(Date:1/15/2014)... 2014  According to Millennium Research Group (MRG), the ... the United States and European ... expand moderately through 2022, with embolization particles representing ... interest in drug-eluting beads (DEBs) and radioembolization spheres ...
(Date:1/15/2014)... 15, 2014 Reportlinker.com announces that ... available in its catalogue: ... for Advanced Drug Delivery Systems -- ... http://www.reportlinker.com/p01941928/Global-Markets-and-Technologies-for-Advanced-Drug-Delivery-Systems----Focus-on-Routes-of-Administration.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology ...
Breaking Medicine Technology:Superbugs No Longer Ride In Rescue Vehicles 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16
...  BioDelivery Sciences International, Inc. (Nasdaq: BDSI ... license and development agreement with Endo Pharmaceuticals (Nasdaq: ... to develop and commercialize BEMA Buprenorphine for the ... patented and proven BioErodible MucoAdhesive (BEMA) technology to ...
... conjunction with its fourth quarter 2011 earnings release (expected to ... Inc. (NYSE: CVD ) is pleased to invite ... will be broadcast live over the Internet on Thursday, January ... , What:       , , , Covance Fourth Quarter 2011 Earnings ...
Cached Medicine Technology:BioDelivery Sciences Announces Worldwide License and Development Agreement with Endo Pharmaceuticals for BEMA Buprenorphine 2BioDelivery Sciences Announces Worldwide License and Development Agreement with Endo Pharmaceuticals for BEMA Buprenorphine 3BioDelivery Sciences Announces Worldwide License and Development Agreement with Endo Pharmaceuticals for BEMA Buprenorphine 4BioDelivery Sciences Announces Worldwide License and Development Agreement with Endo Pharmaceuticals for BEMA Buprenorphine 5
... solid made, manual plate washer for ... dispense and aspirate function ensure proper ... a stand and all necessary tubings. ... as well as any bottles for ...
... MP-1200 is a compact and simple ... internal micropumps enable the system both ... all types of microtiter well. MW-1200 ... in rows of 8 wells or ...
High precision microplate washer for immuno and adherent cell assays. For use with all strip types and full microplate in 96- and 384-well format in both portrait and landscape orientations....
The Wellwash 4 Mk 2 combines high performance and flexibility with reliability, simplicity and ease of use....
Medicine Products: